Skip to main content

Published locations for Neoadjuvant Lapatinib Fails to Surpass Trastuzumab in HER2+ Breast Cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Neoadjuvant Lapatinib Fails to Surpass Trastuzumab in HER2+ Breast Cancer

User login

  • Reset your password
  • /content/neoadjuvant-lapatinib-fails-surpass-trastuzumab-her2-breast-cancer
  • /oncologypractice/article/55022/breast-cancer/neoadjuvant-lapatinib-fails-surpass-trastuzumab-her2
  • /hematology-oncology/article/55022/breast-cancer/neoadjuvant-lapatinib-fails-surpass-trastuzumab-her2
  • /breast-cancer-icymi/article/55022/breast-cancer/neoadjuvant-lapatinib-fails-surpass-trastuzumab-her2